Clinical Trials Directory

Trials / Conditions / Refractory Systemic Lupus Erythematosus

Refractory Systemic Lupus Erythematosus

10 registered clinical trials studyying Refractory Systemic Lupus Erythematosus — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingSELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
NCT07523542
Beijing BiotechPhase 1 / Phase 2
Not Yet RecruitingCD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
NCT07432334
Vinmec Research Institute of Stem Cell and Gene TechnologyPhase 1
Not Yet RecruitingNK510 Cell Therapy for Refractory Systemic Lupus Erythematosus
NCT07083349
Base Therapeutics (Shanghai) Co., Ltd.N/A
RecruitingNK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
NCT06676631
Guangdong Provincial People's HospitalPhase 1
RecruitingA Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus
NCT06530849
Gracell Biotechnologies (Shanghai) Co., Ltd.Phase 1 / Phase 2
RecruitingIM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)
NCT06513429
Peking University Third HospitalN/A
Active Not RecruitingAB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nep
NCT06265220
Artiva Biotherapeutics, Inc.Phase 1
UnknownCNCT19 Cell Injection for Refractory Systemic Lupus Erythematosus
NCT05930314
Peking Union Medical College HospitalEARLY_Phase 1
WithdrawnAutologous Stem Cell Transplantation: International Lupus Trial
NCT05063513
European Society for Blood and Marrow TransplantationPhase 2 / Phase 3
UnknownMesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
NCT00698191
Nanjing Medical UniversityPhase 1 / Phase 2